GlassScriptPhysician profile
Benjamin Davis Motley
NPI 1154703072
$78,609.76
in general payments reported to CMS, 2019-2025
9 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76K · 2023: $1,791 · 2024: $282 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,527 · Travel and Lodging: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,527.22 |
| Travel and Lodging | $1,023.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $75,000.00 | 2022 | |
| Depuy Synthes Sales INC. | $1,299.46 | 2022-2025 | Fibergraft Bg Morsels, Synfix Evolution, Conduit |
| Globus Medical, INC. | $1,023.71 | 2023 | Caliber, Rise-L . Rise-L A/L |
| Smaio Sa | $945.19 | 2022 | |
| Zimvie INC. | $181.73 | 2022-2023 | |
| Medical Device Business Services, INC. | $66.96 | 2025 | Velys |
| Avita Medical Americas, LLC | $54.61 | 2025 | Recell, Permeaderm, Cohealyx |
| Stryker Corporation | $21.00 | 2022 | |
| Merck Sharp & Dohme LLC | $17.10 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Motley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.